Trial Profile
Single-center, randomized, open, controlled by echocardiography to evaluate the effect of serelaxina in the functioning of the right ventricle and its potential in the prognosis of acute heart failure impact.
Status:
Recruiting
Phase of Trial:
Phase III
Latest Information Update: 01 Sep 2015
Price :
$35
*
At a glance
- Drugs Serelaxin (Primary)
- Indications Acute heart failure
- Focus Therapeutic Use
- Acronyms ECO-RELAX
- 01 Sep 2015 New trial record